Characteristics of VITT antibodies in patients vaccinated with Ad26.COV2.S
Blood Adv
.
2023 Jan 24;7(2):246-250.
doi: 10.1182/bloodadvances.2022007336.
Authors
Angela Huynh
1
,
Donald M Arnold
1
2
,
James V Michael
3
,
Rumi Clare
1
,
James W Smith
1
,
Mercy Daka
1
,
Monica Ianosi-Irimie
4
,
Steven E McKenzie
3
,
John G Kelton
1
2
,
Ishac Nazy
1
2
Affiliations
1
Department of Medicine, Michael G. DeGroote School of Medicine.
2
McMaster Centre for Transfusion Research, McMaster University, Hamilton, ON, Canada.
3
Cardeza Foundation for Hematologic Research, Thomas Jefferson University, Philadelphia, PA.
4
Department of Pathology, Cooper University Hospital, Camden, NJ.
PMID:
35377937
PMCID:
PMC9860431
DOI:
10.1182/bloodadvances.2022007336
No abstract available
Publication types
Research Support, Non-U.S. Gov't
MeSH terms
Ad26COVS1*
COVID-19* / prevention & control
Humans
Substances
Ad26COVS1
Grants and funding
452655/CIHR/Canada